North America Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Treatment (Pharmaceuticals, and Devices), By Gender (Male, and Female), By Sales Channel, By Country and Growth Forecast, 2023

List of Tables

The North America Androgenetic Alopecia Market would witness market growth of 6.8% CAGR during the forecast period (2023-2030).

The US market dominated the North America Androgenetic Alopecia Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,143.2 Million by 2030. The Canada market is experiencing a CAGR of 9.2% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 8.3% during (2023 - 2030).

One of the primary drivers of adoption in the androgenetic alopecia market is the growing awareness and acceptance of hair loss as a common condition. As public understanding of androgenetic alopecia expands, more individuals seek information and solutions to address their concerns. This increased awareness has led to a shift in societal attitudes, with a greater acceptance of seeking medical or cosmetic interventions for hair loss. A decreasing stigma is associated with seeking cosmetic enhancements for both men and women. As societal norms change, individuals are more open to exploring various interventions to address their hair loss concerns, contributing to the overall adoption of treatments within the market.

Media and social media platforms are crucial in shaping beauty standards and influencing individual choices. Celebrity endorsements and testimonials regarding hair restoration treatments have become common, impacting the adoption rates within the market. High-profile figures openly discussing their experiences with hair loss treatments contribute to the normalization of seeking such interventions. Individuals from diverse locations can access information about different treatment options, connect with specialists, and choose interventions that suit their preferences and needs.

As per the International Trade Administration (ITA), in the first half of 2022, the Canadian cosmetics industry was the fastest-growing industry in the country. In 2022, Canada's personal care and beauty sector earned around $11 billion in revenue. Advancements in technology, such as laser therapy, platelet-rich plasma (PRP) treatments, and robotic hair transplantation, are gaining popularity in Canada. Celebrity endorsements, media representation, and the influence of social media contribute to shaping beauty standards and aesthetic preferences in Canada. Also, ITA estimates by 2024, cosmetic industry revenue is anticipated to increase by 1.45% yearly to USD 1.8 billion. Hence, the factors mentioned above will drive the regional market growth.

Based on Treatment, the market is segmented into Pharmaceuticals, and Devices. Based on Gender, the market is segmented into Male, and Female. Based on Sales Channel, the market is segmented into Prescriptions, and OTC. Based on End-use, the market is segmented into Dermatology Clinics, and Homecare Settings. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

Cipla Limited
Merck & Co., Inc.
GlaxoSmithKline PLC (GSK)
Sun Pharmaceuticals Industries Ltd.
Dr. Reddy's Laboratories Ltd.
Aurobindo Pharma Limited
Pfizer, Inc.
Lutronic Co., Ltd.
Viatris Inc.
Eli Lilly and Company

North America Androgenetic Alopecia Market Report Segmentation

By Treatment

Pharmaceuticals
Devices

By Gender

Male
Female

By Sales Channel

Prescriptions
OTC

By End-use

Dermatology Clinics
Homecare Settings

By Country

US
Canada
Mexico
Rest of North America

Chapter 1.Market Scope & Methodology

1.1Market Definition
1.2Objectives
1.3Market Scope
1.4Segmentation
- 1.4.1North America Androgenetic Alopecia Market, by Treatment
- 1.4.2North America Androgenetic Alopecia Market, by Gender
- 1.4.3North America Androgenetic Alopecia Market, by Sales Channel
- 1.4.4North America Androgenetic Alopecia Market, by End-use
- 1.4.5North America Androgenetic Alopecia Market, by Country
1.5Methodology for the research

Chapter 2.Market at a Glance

2.1Key Highlights

Chapter 3.Market Overview

3.1Introduction
- 3.1.1Overview
  - 3.1.1.1Market Composition and Scenario
3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Restraints
- 3.2.3Market Opportunities
- 3.2.4Market Challenges
3.3Porter Five Forces Analysis

Chapter 4.North America Androgenetic Alopecia Market, By Treatment

4.1North America Pharmaceuticals Market, By Country
4.2North America Devices Market, By Country

Chapter 5.North America Androgenetic Alopecia Market, By Gender

5.1North America Male Market, By Country
5.2North America Female Market, By Country

Chapter 6.North America Androgenetic Alopecia Market, By Sales Channel

6.1North America Prescriptions Market, By Country
6.2North America OTC Market, By Country

Chapter 7.North America Androgenetic Alopecia Market, By End-use

7.1North America Dermatology Clinics Market, By Country
7.2North America Homecare Settings Market, By Country

Chapter 8.North America Androgenetic Alopecia Market, By Country

8.1US Androgenetic Alopecia Market
- 8.1.1US Androgenetic Alopecia Market, By Treatment
- 8.1.2US Androgenetic Alopecia Market, By Gender
- 8.1.3US Androgenetic Alopecia Market, By Sales Channel
- 8.1.4US Androgenetic Alopecia Market, By End-use
8.2Canada Androgenetic Alopecia Market
- 8.2.1Canada Androgenetic Alopecia Market, By Treatment
- 8.2.2Canada Androgenetic Alopecia Market, By Gender
- 8.2.3Canada Androgenetic Alopecia Market, By Sales Channel
- 8.2.4Canada Androgenetic Alopecia Market, By End-use
8.3Mexico Androgenetic Alopecia Market
- 8.3.1Mexico Androgenetic Alopecia Market, By Treatment
- 8.3.2Mexico Androgenetic Alopecia Market, By Gender
- 8.3.3Mexico Androgenetic Alopecia Market, By Sales Channel
- 8.3.4Mexico Androgenetic Alopecia Market, By End-use
8.4Rest of North America Androgenetic Alopecia Market
- 8.4.1Rest of North America Androgenetic Alopecia Market, By Treatment
- 8.4.2Rest of North America Androgenetic Alopecia Market, By Gender
- 8.4.3Rest of North America Androgenetic Alopecia Market, By Sales Channel
- 8.4.4Rest of North America Androgenetic Alopecia Market, By End-use

Chapter 9.Company Profiles

9.1Cipla Limited
- 9.1.1Company Overview
- 9.1.2Financial Analysis
- 9.1.3Segmental and Regional Analysis
- 9.1.4Research & Development Expense
- 9.1.5SWOT Analysis
9.2Merck & Co., Inc.
- 9.2.1Company Overview
- 9.2.2Financial Analysis
- 9.2.3Segmental and Regional Analysis
- 9.2.4Research & Development Expenses
- 9.2.5SWOT Analysis
9.3GlaxoSmithKline PLC (GSK)
- 9.3.1Company Overview
- 9.3.2Financial Analysis
- 9.3.3Regional Analysis
- 9.3.4Research & Development Expense
- 9.3.5SWOT Analysis
9.4Sun Pharmaceuticals Industries Ltd.
- 9.4.1Company Overview
- 9.4.2Financial Analysis
- 9.4.3Regional Analysis
- 9.4.4Research & Development Expenses
- 9.4.5SWOT Analysis
9.5Dr. Reddy's Laboratories Ltd.
- 9.5.1Company Overview
- 9.5.2Financial Analysis
- 9.5.3Segmental and Regional Analysis
- 9.5.4Research & Development Expense
- 9.5.5Recent strategies and developments:
  - 9.5.5.1Product Launches and Product Expansions:
- 9.5.6SWOT Analysis
9.6Aurobindo Pharma Limited
- 9.6.1Company Overview
- 9.6.2Financial Analysis
- 9.6.3Regional Analysis
- 9.6.4Research & Development Expense
- 9.6.5SWOT Analysis
9.7Pfizer, Inc.
- 9.7.1Company Overview
- 9.7.2Financial Analysis
- 9.7.3Regional & Segmental Analysis
- 9.7.4Research & Development Expense
- 9.7.5Recent strategies and developments:
  - 9.7.5.1Trails and Approvals:
- 9.7.6SWOT Analysis
9.8Lutronic Co., Ltd.
- 9.8.1Company Overview
- 9.8.2Financial Analysis
- 9.8.3Regional Analysis
- 9.8.4Research & Development Expenses
- 9.8.5SWOT Analysis
9.9Viatris, Inc.
- 9.9.1Company Overview
- 9.9.2Financial Analysis
- 9.9.3Segmental Analysis
- 9.9.4Research & Development Expense
- 9.9.5SWOT Analysis
9.10.Eli Lilly And Company
- 9.10.1Company Overview
- 9.10.2Financial Analysis
- 9.10.3Regional Analysis
- 9.10.4Research & Development Expenses
- 9.10.5SWOT Analysis

LIST OF TABLES

TABLE 1North America Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 2North America Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 3North America Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 4North America Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 5North America Pharmaceuticals Market, By Country, 2019 - 2022, USD Million
TABLE 6North America Pharmaceuticals Market, By Country, 2023 - 2030, USD Million
TABLE 7North America Devices Market, By Country, 2019 - 2022, USD Million
TABLE 8North America Devices Market, By Country, 2023 - 2030, USD Million
TABLE 9North America Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 10North America Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 11North America Male Market, By Country, 2019 - 2022, USD Million
TABLE 12North America Male Market, By Country, 2023 - 2030, USD Million
TABLE 13North America Female Market, By Country, 2019 - 2022, USD Million
TABLE 14North America Female Market, By Country, 2023 - 2030, USD Million
TABLE 15North America Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 16North America Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 17North America Prescriptions Market, By Country, 2019 - 2022, USD Million
TABLE 18North America Prescriptions Market, By Country, 2023 - 2030, USD Million
TABLE 19North America OTC Market, By Country, 2019 - 2022, USD Million
TABLE 20North America OTC Market, By Country, 2023 - 2030, USD Million
TABLE 21North America Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 22North America Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 23North America Dermatology Clinics Market, By Country, 2019 - 2022, USD Million
TABLE 24North America Dermatology Clinics Market, By Country, 2023 - 2030, USD Million
TABLE 25North America Homecare Settings Market, By Country, 2019 - 2022, USD Million
TABLE 26North America Homecare Settings Market, By Country, 2023 - 2030, USD Million
TABLE 27North America Androgenetic Alopecia Market, By Country, 2019 - 2022, USD Million
TABLE 28North America Androgenetic Alopecia Market, By Country, 2023 - 2030, USD Million
TABLE 29US Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 30US Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 31US Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 32US Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 33US Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 34US Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 35US Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 36US Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 37US Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 38US Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 39Canada Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 40Canada Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 41Canada Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 42Canada Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 43Canada Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 44Canada Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 45Canada Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 46Canada Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 47Canada Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 48Canada Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 49Mexico Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 50Mexico Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 51Mexico Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 52Mexico Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 53Mexico Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 54Mexico Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 55Mexico Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 56Mexico Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 57Mexico Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 58Mexico Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 59Rest of North America Androgenetic Alopecia Market, 2019 - 2022, USD Million
TABLE 60Rest of North America Androgenetic Alopecia Market, 2023 - 2030, USD Million
TABLE 61Rest of North America Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
TABLE 62Rest of North America Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
TABLE 63Rest of North America Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
TABLE 64Rest of North America Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
TABLE 65Rest of North America Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
TABLE 66Rest of North America Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
TABLE 67Rest of North America Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
TABLE 68Rest of North America Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
TABLE 69Key Information - Cipla Limited
TABLE 70Key Information - Merck & Co., Inc.
TABLE 71Key Information - GlaxoSmithKline PLC
TABLE 72Key Information - Sun Pharmaceuticals Industries Ltd.
TABLE 73Key Information - Dr. Reddy's Laboratories Ltd.
TABLE 74key information - Aurobindo Pharma Limited
TABLE 75Key Information - Pfizer, Inc.
TABLE 76Key Information - lUTRONIC cO., lTD.
TABLE 77key information - Viatris, Inc.
TABLE 78Key Information - Eli Lilly And Company

North America Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Treatment (Pharmaceuticals, and Devices), By Gender (Male, and Female), By Sales Channel, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents